| Stephen Derrick Milhollin Jr, DO | |
|
1800 10th Ave, Columbus, GA 31901-1529 | |
| (706) 571-1120 | |
| Not Available |
| Full Name | Stephen Derrick Milhollin Jr |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1800 10th Ave, Columbus, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265993406 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 97198 (Georgia) | Primary |
| Entity Name | Columbus Ambulatory Healthcare Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790733244 PECOS PAC ID: 1355244385 Enrollment ID: O20040128000790 |
News Archive
Analysis of blood protein data from the Women's Health Initiative cohorts has revealed new biomarkers for stroke and coronary heart disease (CHD). Research published in BioMed Central's open access journal Genome Medicine found that beta-2 microglobulin (B2M) levels were significantly elevated in postmenopausal women with CHD, and insulin-like growth factor binding protein 4 (IGFBP4) was strongly associated with stroke.
W. L. Gore & Associates (Gore) today announced that Instituto Nacional De Cardiologia in Mexico City, Mexico, is the first hospital in the country to use the GORE® HELEX Septal Occluder for the transcatheter closure of an atrial septal defect (ASD). Department Chief, Dr. Carlos Zabal and Dr. Jose Garcia Montes of the Instituto Nacional de Cardiologia, in Mexico City, achieved the milestone procedure in March, 2010.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
Researchers have learned more about how a leading drug prevents certain types of arthritis from eating away at bone, according to a study published in the March edition of the Annals of the Rheumatic Diseases.
› Verified 8 days ago
| Entity Name | The Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255401519 PECOS PAC ID: 9830094077 Enrollment ID: O20040630000391 |
News Archive
Analysis of blood protein data from the Women's Health Initiative cohorts has revealed new biomarkers for stroke and coronary heart disease (CHD). Research published in BioMed Central's open access journal Genome Medicine found that beta-2 microglobulin (B2M) levels were significantly elevated in postmenopausal women with CHD, and insulin-like growth factor binding protein 4 (IGFBP4) was strongly associated with stroke.
W. L. Gore & Associates (Gore) today announced that Instituto Nacional De Cardiologia in Mexico City, Mexico, is the first hospital in the country to use the GORE® HELEX Septal Occluder for the transcatheter closure of an atrial septal defect (ASD). Department Chief, Dr. Carlos Zabal and Dr. Jose Garcia Montes of the Instituto Nacional de Cardiologia, in Mexico City, achieved the milestone procedure in March, 2010.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
Researchers have learned more about how a leading drug prevents certain types of arthritis from eating away at bone, according to a study published in the March edition of the Annals of the Rheumatic Diseases.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Derrick Milhollin Jr, DO 806 Abingdon Way, Atlanta, GA 30328-1686 Ph: (706) 878-0749 | Stephen Derrick Milhollin Jr, DO 1800 10th Ave, Columbus, GA 31901-1529 Ph: (706) 571-1120 |
News Archive
Analysis of blood protein data from the Women's Health Initiative cohorts has revealed new biomarkers for stroke and coronary heart disease (CHD). Research published in BioMed Central's open access journal Genome Medicine found that beta-2 microglobulin (B2M) levels were significantly elevated in postmenopausal women with CHD, and insulin-like growth factor binding protein 4 (IGFBP4) was strongly associated with stroke.
W. L. Gore & Associates (Gore) today announced that Instituto Nacional De Cardiologia in Mexico City, Mexico, is the first hospital in the country to use the GORE® HELEX Septal Occluder for the transcatheter closure of an atrial septal defect (ASD). Department Chief, Dr. Carlos Zabal and Dr. Jose Garcia Montes of the Instituto Nacional de Cardiologia, in Mexico City, achieved the milestone procedure in March, 2010.
Celsion Corporation, a leading oncology drug development company, today announced financial results for the fourth quarter and year ended December 31, 2009. Management also highlighted the progress made in clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin, including the Company's pivotal Phase III trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer, and recurrent chest wall breast cancer.
Researchers have learned more about how a leading drug prevents certain types of arthritis from eating away at bone, according to a study published in the March edition of the Annals of the Rheumatic Diseases.
› Verified 8 days ago
Clayton Paul Michael Bellam, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8400 Veterans Pkwy Apt 802, Columbus, GA 31909 Phone: 770-906-0084 | |
Dr. Jeffrey S Jenkins, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 10th Ave, Suite 200, Columbus, GA 31901 Phone: 706-321-3745 Fax: 706-321-3749 | |
Dr. Jefferson C Jones, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 10th Ave, Suite 200, Columbus, GA 31901 Phone: 706-321-3745 Fax: 706-321-3749 | |
Dr. Robert O'neil Snoddy, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 610 19th St, Columbus, GA 31901 Phone: 706-322-7884 Fax: 706-660-2167 | |
Dr. Lisa W. Gantner, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7901 Veterans Pkwy, Columbus, GA 31909 Phone: 706-321-1223 Fax: 706-321-0819 | |
Shikha Shah, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6200 Bradley Park Dr, Columbus, GA 31904 Phone: 706-591-8080 Fax: 888-905-2571 | |
Anthony Iwelunmor, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 710 Center St, Columbus, GA 31901 Phone: 706-571-1000 |